Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals